Blood Glucose Meters vs Continuous Glucose Monitors: How Each Tracks Blood Sugar

How Each Technology Works

Blood glucose meters (BGMs) and continuous glucose monitors (CGMs) both measure glucose — but they analyze different biological fluids using fundamentally different mechanisms.

A BGM uses electrochemical detection. The user lances a fingertip, places a small blood droplet on a test strip, and the strip's enzyme (typically glucose oxidase) reacts with glucose in the blood. The resulting electrical current is converted into a milligrams-per-deciliter (mg/dL) reading in seconds. The process directly samples capillary blood, which is considered the clinical reference standard for glucose concentration.

A CGM uses a tiny subcutaneous sensor — a flexible filament inserted just beneath the skin — to measure glucose in interstitial fluid, the fluid surrounding tissue cells. A transmitter attached to the sensor sends data wirelessly to a receiver or smartphone every one to five minutes. Because interstitial glucose lags behind blood glucose by roughly five to fifteen minutes, CGM readings may diverge from fingerstick values during periods of rapid glucose change, such as after a meal or during exercise. See how CGM sensors measure glucose in real time for a deeper look at the underlying technology.

Data Output: Snapshot vs. Stream

The most clinically meaningful difference between the two devices is the type of information they provide.

A BGM delivers a single data point: your glucose concentration at the exact moment of the test. That number is valuable but context-free — it cannot tell you whether glucose is rapidly rising after breakfast or slowly drifting down toward hypoglycemia.

CGMs generate a continuous data stream and display trend arrows indicating the direction and rate of glucose change. A reading of 110 mg/dL with a rapidly falling arrow carries entirely different clinical implications than a stable 110 mg/dL. This dynamic information helps clinicians and patients make more timely decisions around meals, activity, and medication timing.

CGMs also produce ambulatory glucose profiles (AGPs) — standardized reports summarizing glucose variability, time-in-range, and hypoglycemia exposure over days or weeks. These reports have become a recognized tool for diabetes management review. BGMs can generate logbooks of individual readings, but they cannot replicate trend analysis without very frequent manual testing.

For a broader overview of devices that track vital health metrics at home, the field guide to home health monitoring devices provides useful context.

Accuracy, Calibration, and Clinical Use

The FDA evaluates both device types under distinct accuracy frameworks. BGMs are assessed against ISO 15197 standards, which require that 95% of readings fall within 15 mg/dL of a laboratory reference value (for readings below 100 mg/dL) or within 15% (for higher readings). Modern BGMs from cleared manufacturers generally meet or exceed these thresholds when used correctly.

CGMs are evaluated for mean absolute relative difference (MARD) against venous or capillary reference values. MARD figures for current-generation devices typically range from approximately 8% to 10%, though accuracy can be affected by sensor placement, hydration status, certain medications, and periods of rapid glucose change.

Some CGM systems are cleared as iCGM (integrated CGM), meaning their data can be used to drive automated insulin delivery systems without routine fingerstick confirmation. Others still recommend periodic BGM verification. Clinicians determine which approach is appropriate based on the patient's condition, therapeutic goals, and the specific devices involved.

You can explore how these two approaches compare in practice at CGMs vs. traditional fingerstick testing, which covers trade-offs relevant to conversations with your care team.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any decisions about glucose monitoring or diabetes management.